- September 17, 2022
- Newsletter
- 617-430-5616
Menu
» Home » CAD » Infectious Disease » Viral Infection Diseases » Cytomegalovirus (CMV)
ADVERTISEMENT
ADVERTISEMENT
» Home » CAD » Infectious Disease » Viral Infection Diseases » Cytomegalovirus (CMV)
Background
Epidemiology
Anatomy
Pathophysiology
Etiology
Genetics
Prognostic Factors
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
900
mg
Tablet
Orally
every 12 hrs
21
days
After induction therapy or in people with inactive CMV retinitis, maintenance dosage is 900 mg orally per day.
Indicated for Cytomegalovirus infection prophylaxis The recommended dose is 480 mg PO/IV once a day, and treatment should begin within 28 days after transplantation, either before or after engraftment, and should continue until Day 100
cytomegalovirus immune globulin (CMV IG)
Kidney Transplant
Administer intravenous infusion of 150 mg/kg within 72 hours after the transplant, after that 100 mg/kg at 2-, 4-, 6-, and 8 weeks post-transplantation, and then 50 mg/kg at 12 and 16 weeks post-transplantation
Liver, Pancreas, Heart, Lung Transplant
Administer intravenous infusion of 150 mg/kg within 72 hours after the transplant, after that 2-, 4-, 6-, and 8 weeks post-transplantation, and then 100 mg/kg at 12 and 16 weeks post-transplantation
CMV Pneumonia (Orphan)
For use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients
Renal Impairment
Use carefully
Take dose of 400 mg orally two times a day with or without meal
Dosage Modifications
Coadministration with anticonvulsants
Raise the dose up to 800 mg, twice a day and if carbamazepine is also being taken
Phenobarbital or phenytoin administered concurrently: the dosage be increased to 1200 mg twice a day
Renal impairment
Mild-to-severe: No dose adjustment necessary
End-stage renal disease: No study performed
Hepatic impairment
Mild-to-moderate: No dosage adjustment necessary
Severe: No study performed
Take dose of 400 mg orally two times a day with or without meal
Dosage Modifications
Coadministration with anticonvulsants
Raise the dose up to 800 mg, twice a day and if carbamazepine is also being taken
Phenobarbital or phenytoin administered concurrently: the dosage be increased to 1200 mg twice a day
Renal impairment
Mild-to-severe: No dose adjustment necessary
End-stage renal disease: No study performed
Hepatic impairment
Mild-to-moderate: No dosage adjustment necessary
Severe: No study performed
Take dose of 400 mg orally twice a day with or without meal
Dosage Modifications
Coadministration with anticonvulsants
Raise the dose up to 800 mg, twice a day and if carbamazepine is also being taken
Phenobarbital or phenytoin administered concurrently: the dosage be increased to 1200 mg twice a day
Renal impairment
Mild-to-severe: No dose adjustment necessary
End-stage renal disease: No study performed
Hepatic impairment
Mild-to-moderate: No dose adjustment necessary
Severe: No study performed
Future Trends
References
ADVERTISEMENT
» Home » CAD » Infectious Disease » Viral Infection Diseases » Cytomegalovirus (CMV)
900
mg
Tablet
Orally
every 12 hrs
21
days
After induction therapy or in people with inactive CMV retinitis, maintenance dosage is 900 mg orally per day.
Indicated for Cytomegalovirus infection prophylaxis The recommended dose is 480 mg PO/IV once a day, and treatment should begin within 28 days after transplantation, either before or after engraftment, and should continue until Day 100
cytomegalovirus immune globulin (CMV IG)
Kidney Transplant
Administer intravenous infusion of 150 mg/kg within 72 hours after the transplant, after that 100 mg/kg at 2-, 4-, 6-, and 8 weeks post-transplantation, and then 50 mg/kg at 12 and 16 weeks post-transplantation
Liver, Pancreas, Heart, Lung Transplant
Administer intravenous infusion of 150 mg/kg within 72 hours after the transplant, after that 2-, 4-, 6-, and 8 weeks post-transplantation, and then 100 mg/kg at 12 and 16 weeks post-transplantation
CMV Pneumonia (Orphan)
For use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients
Renal Impairment
Use carefully
Take dose of 400 mg orally two times a day with or without meal
Dosage Modifications
Coadministration with anticonvulsants
Raise the dose up to 800 mg, twice a day and if carbamazepine is also being taken
Phenobarbital or phenytoin administered concurrently: the dosage be increased to 1200 mg twice a day
Renal impairment
Mild-to-severe: No dose adjustment necessary
End-stage renal disease: No study performed
Hepatic impairment
Mild-to-moderate: No dosage adjustment necessary
Severe: No study performed
Take dose of 400 mg orally two times a day with or without meal
Dosage Modifications
Coadministration with anticonvulsants
Raise the dose up to 800 mg, twice a day and if carbamazepine is also being taken
Phenobarbital or phenytoin administered concurrently: the dosage be increased to 1200 mg twice a day
Renal impairment
Mild-to-severe: No dose adjustment necessary
End-stage renal disease: No study performed
Hepatic impairment
Mild-to-moderate: No dosage adjustment necessary
Severe: No study performed
Take dose of 400 mg orally twice a day with or without meal
Dosage Modifications
Coadministration with anticonvulsants
Raise the dose up to 800 mg, twice a day and if carbamazepine is also being taken
Phenobarbital or phenytoin administered concurrently: the dosage be increased to 1200 mg twice a day
Renal impairment
Mild-to-severe: No dose adjustment necessary
End-stage renal disease: No study performed
Hepatic impairment
Mild-to-moderate: No dose adjustment necessary
Severe: No study performed
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.